Non-Operating Income/Expense (Annual)

Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.

AVANOS MEDICAL, INC. (AVNS) had Non-Operating Income/Expense of $-8.80M for the most recently reported fiscal year, ending 2022-12-31.

Quarterly Annual

Figures for fiscal year ending 2022-12-31

Income Statement Financials
Revenue	$820.00M
Net Income	$50.50M
Cost of Goods Sold	$370.00M
Gross Profit	$450.00M
Operating Expenses	$746.00M
Operating Income	$74.00M
Non-Operating Income/Expense	$-8.80M
Pre-Tax Income	$65.20M
Normalized Pre-Tax Income	$65.20M
Income after Taxes	$50.50M
Income from Continuous Operations	$50.50M
Consolidated Net Income/Loss	$50.50M
Normalized Income after Taxes	$50.50M
EBIT	$74.00M
EBITDA	$121.70M
Weighted-Average Shares Outstanding (Basic)	46.90M
Weighted-Average Shares Outstanding (Diluted)	47.30M
Earnings per Share (EPS) (Basic)	$1.08
Earnings per Share (EPS) (Diluted)	$1.07
Balance Sheet Financials
Current Assets	$499.80M
Property, Plant, and Equipment	$163.90M
Long-Term Assets	$1.29B
Total Assets	$1.79B
Current Liabilities	$185.80M
Long-Term Debt	$226.30M
Long-Term Liabilities	$309.90M
Total Liabilities	$495.70M
Common Equity	$1.29B
Tangible Shareholders Equity	$220.80M
Shareholders Equity	$1.29B
Common Shares Outstanding	46.53M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$90.90M
Cash Flow from Investing Activities	$-135.40M
Cash Flow from Financial Activities	$56.70M
Beginning Cash	$118.50M
End Cash	$127.70M
Increase/Decrease in Cash	$9.20M
Stock-Based Compensation	$15.90M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.69
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.15
Debt to Equity Ratio	0.18
Gross Margin	54.88%
Operating Margin	9.02%
EBIT Margin	9.02%
EBITDA Margin	14.84%
Pre-Tax Profit Margin	7.95%
Profit Margin	6.16%
Free Cash Flow	$71.60M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.46
Inventory Turnover	1.94
Receiveable Turnover	4.88
Days Sales in Receivables	74.74
Return on Equity	3.91%
Return on Tangible Equity	22.87%
Return on Assets	2.83%
Return on Investments	3.33%
Book Value Per Share	$27.75
Free Cash Flow per Share	$1.51
Operating Cash Flow per Share	$1.92

Data from Zacks Investment Research, Inc.